These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7534850)

  • 1. Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms.
    Schaffner DL; Barrios R; Shaker MR; Rajagopalan S; Huang SL; Tindall DJ; Young CY; Overbeek PA; Lebovitz RM; Lieberman MW
    Lab Invest; 1995 Mar; 72(3):283-90. PubMed ID: 7534850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of salivary gland tumors in pleomorphic adenoma gene 1 transgenic mice].
    Zhao XD; Yang WJ; Wang L; Kong H; Ren WH; Zhang M; Fei J; Zhang CP; Wang ZG
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):390-5. PubMed ID: 14556190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene.
    Nielsen LL; Discafani CM; Gurnani M; Tyler RD
    Cancer Res; 1991 Jul; 51(14):3762-7. PubMed ID: 2065330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
    Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
    Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
    Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
    Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice.
    Sandmöller A; Halter R; Gómez-La-Hoz E; Gröne HJ; Suske G; Paul D; Beato M
    Oncogene; 1994 Oct; 9(10):2805-15. PubMed ID: 8084586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter.
    Santelli G; de Franciscis V; Portella G; Chiappetta G; D'Alessio A; Califano D; Rosati R; Mineo A; Monaco C; Manzo G
    Cancer Res; 1993 Nov; 53(22):5523-7. PubMed ID: 8221693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression.
    Declercq J; Van Dyck F; Braem CV; Van Valckenborgh IC; Voz M; Wassef M; Schoonjans L; Van Damme B; Fiette L; Van de Ven WJ
    Cancer Res; 2005 Jun; 65(11):4544-53. PubMed ID: 15930271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
    Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
    Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX
    Oncogene; 2001 Mar; 20(12):1445-54. PubMed ID: 11313888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model.
    Adnane J; Jackson RJ; Nicosia SV; Cantor AB; Pledger WJ; Sebti SM
    Oncogene; 2000 Nov; 19(47):5338-47. PubMed ID: 11103935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice.
    Lin HH; Xiong Y; Ho YS; Zhou B; Nguyen HV; Deng H; Lee R; Yen Y; Borok Z; Ann DK
    Eur J Oral Sci; 2007 Feb; 115(1):30-9. PubMed ID: 17305714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization.
    Chiappetta G; Fabien N; Picone A; Califano D; Monaco C; de Franciscis V; Vecchio G; Santelli G
    Oncol Res; 1996; 8(2):85-93. PubMed ID: 8859779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.
    Cleutjens KB; van der Korput HA; Ehren-van Eekelen CC; Sikes RA; Fasciana C; Chung LW; Trapman J
    Mol Endocrinol; 1997 Aug; 11(9):1256-65. PubMed ID: 9259317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
    Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.